The U.S. Food and Drug Administration (FDA) recently announced it would develop a new review framework for AI and machine learning-based medical devices.

Currently, a medical device’s algorithm has to be “locked” by the manufacturer before it is given approval by the FDA. “Locked” algorithms provide the same result each time the same input is given, while an adaptive algorithm, which utilizes AI, changes its behavior using a defined learning process.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]